Original: $114 Bundle Price: $105 You Save: $9 $89.00 2 in stock 2 in stock A research bundle combining CJC-1295 (No DAC) and Ipamorelin or GH/IGF-1 axis studies in controlled laboratory settings
This shows a promising therapeutic potential of G
Why, after all the alcohol has been expelled from our body, do we still experience an alcohol hangover
Ipamorelin + CJC-1295 Stack: Evidence, Mechanism, and Protocol At a glance Drug class / Growth hormone secretagogue (GHRP) + Growth hormone-releasing hormone analogue (GHRH analogue) Ipamorelin receptor target / Ghrelin receptor (GHSR-1a), selective, no cortisol or prolactin spike CJC-1295 receptor target / GHRH receptor (GHRHR) on pituitary somatotrophs Combination mechanism / GHRP + GHRH co-stimulation raises GH pulse amplitude 2-to-10-fold over either agent alone in animal models Typical ipamorelin dose / 100-300 mcg subcutaneous injection, 1-3x daily Typical CJC-1295 (no DAC) dose / 100-300 mcg subcutaneous injection, timed with ipamorelin Typical CJC-1295 with DAC dose / 1,000-2,000 mcg subcutaneous injection, once weekly Primary evidence level / Mechanistic + animal + one Phase II RCT (CJC-1295)
Concerns exist regarding potential direct passage into the bloodstream via gut tight junctions, bypassing normal digestive processes
Your natural regulation stays in place
